ID   MARF1_RAT               Reviewed;        1735 AA.
AC   Q8VIG2; F1LNE9;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2012, sequence version 2.
DT   29-MAY-2024, entry version 148.
DE   RecName: Full=Meiosis regulator and mRNA stability factor 1 {ECO:0000312|RGD:619770};
DE   AltName: Full=Limkain-b1;
DE   AltName: Full=Meiosis arrest female protein 1 {ECO:0000305};
GN   Name=Marf1 {ECO:0000312|RGD:619770}; Synonyms=Lkap;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH LIMK2.
RA   Miyamoto K., Nakamura T., Shirakawa K., Matsumoto K.;
RT   "Molecular cloning and characterization of novel large protein, limkain b1,
RT   which associates with the LIM-kinase 2.";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
CC   -!- FUNCTION: Essential regulator of oogenesis required for female meiotic
CC       progression to repress transposable elements and preventing their
CC       mobilization, which is essential for the germline integrity. Probably
CC       acts via some RNA metabolic process, equivalent to the piRNA system in
CC       males, which mediates the repression of transposable elements during
CC       meiosis by forming complexes composed of RNAs and governs the
CC       methylation and subsequent repression of transposons. Also required to
CC       protect from DNA double-strand breaks (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with LIMK2. {ECO:0000269|Ref.1}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB012133; BAB82432.1; -; mRNA.
DR   RefSeq; NP_596912.1; NM_133421.2.
DR   RefSeq; XP_003750827.1; XM_003750779.4.
DR   AlphaFoldDB; Q8VIG2; -.
DR   SMR; Q8VIG2; -.
DR   IntAct; Q8VIG2; 2.
DR   STRING; 10116.ENSRNOP00000073018; -.
DR   iPTMnet; Q8VIG2; -.
DR   PhosphoSitePlus; Q8VIG2; -.
DR   jPOST; Q8VIG2; -.
DR   PaxDb; 10116-ENSRNOP00000068225; -.
DR   Ensembl; ENSRNOT00000091520.2; ENSRNOP00000073018.1; ENSRNOG00000056248.2.
DR   Ensembl; ENSRNOT00055008387; ENSRNOP00055006341; ENSRNOG00055005225.
DR   Ensembl; ENSRNOT00060021347; ENSRNOP00060016847; ENSRNOG00060012580.
DR   Ensembl; ENSRNOT00065003574; ENSRNOP00065002466; ENSRNOG00065002660.
DR   GeneID; 170946; -.
DR   KEGG; rno:170946; -.
DR   UCSC; RGD:619770; rat.
DR   AGR; RGD:619770; -.
DR   CTD; 9665; -.
DR   RGD; 619770; Marf1.
DR   eggNOG; ENOG502QUYZ; Eukaryota.
DR   GeneTree; ENSGT00390000002393; -.
DR   HOGENOM; CLU_002701_0_0_1; -.
DR   InParanoid; Q8VIG2; -.
DR   OMA; SCCGKLH; -.
DR   OrthoDB; 5311892at2759; -.
DR   TreeFam; TF329117; -.
DR   PRO; PR:Q8VIG2; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000056248; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005777; C:peroxisome; ISO:RGD.
DR   GO; GO:1905762; F:CCR4-NOT complex binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0004540; F:RNA nuclease activity; IEA:InterPro.
DR   GO; GO:0006302; P:double-strand break repair; ISO:RGD.
DR   GO; GO:0007143; P:female meiotic nuclear division; ISS:UniProtKB.
DR   GO; GO:0048477; P:oogenesis; ISS:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; ISS:UniProtKB.
DR   CDD; cd09978; LOTUS_2_Limkain_b1; 1.
DR   CDD; cd09979; LOTUS_3_Limkain_b1; 1.
DR   CDD; cd09980; LOTUS_4_Limkain_b1; 1.
DR   CDD; cd09981; LOTUS_5_Limkain_b1; 1.
DR   CDD; cd09983; LOTUS_7_Limkain_b1; 1.
DR   CDD; cd09984; LOTUS_8_Limkain_b1; 1.
DR   CDD; cd10910; PIN_limkain_b1_N_like; 1.
DR   CDD; cd12255; RRM1_LKAP; 1.
DR   CDD; cd12256; RRM2_LKAP; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   Gene3D; 3.40.50.1010; 5'-nuclease; 1.
DR   Gene3D; 3.30.420.610; LOTUS domain-like; 6.
DR   InterPro; IPR041966; LOTUS-like.
DR   InterPro; IPR024768; Marf1.
DR   InterPro; IPR045602; MARF1_LOTUS.
DR   InterPro; IPR034189; MARF1_RRM1.
DR   InterPro; IPR034191; MARF1_RRM2.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR021139; NYN.
DR   InterPro; IPR025605; OST-HTH/LOTUS_dom.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR14379; LIMKAIN B LKAP; 1.
DR   PANTHER; PTHR14379:SF82; MEIOSIS REGULATOR AND MRNA STABILITY FACTOR 1; 1.
DR   Pfam; PF19687; MARF1_LOTUS; 1.
DR   Pfam; PF11608; MARF1_RRM1; 1.
DR   Pfam; PF01936; NYN; 1.
DR   Pfam; PF12872; OST-HTH; 6.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 2.
DR   PROSITE; PS51644; HTH_OST; 8.
DR   PROSITE; PS50102; RRM; 1.
PE   1: Evidence at protein level;
KW   Differentiation; Meiosis; Oogenesis; Peroxisome; Phosphoprotein;
KW   Reference proteome; Repeat; RNA-binding.
FT   CHAIN           1..1735
FT                   /note="Meiosis regulator and mRNA stability factor 1"
FT                   /id="PRO_0000276848"
FT   DOMAIN          351..488
FT                   /note="NYN"
FT   DOMAIN          788..867
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          872..946
FT                   /note="HTH OST-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00975"
FT   DOMAIN          1000..1076
FT                   /note="HTH OST-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00975"
FT   DOMAIN          1096..1170
FT                   /note="HTH OST-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00975"
FT   DOMAIN          1172..1248
FT                   /note="HTH OST-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00975"
FT   DOMAIN          1256..1331
FT                   /note="HTH OST-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00975"
FT   DOMAIN          1332..1407
FT                   /note="HTH OST-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00975"
FT   DOMAIN          1408..1482
FT                   /note="HTH OST-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00975"
FT   DOMAIN          1483..1557
FT                   /note="HTH OST-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00975"
FT   REGION          617..639
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          657..721
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1671..1718
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        664..693
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        701..716
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         65
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4F3"
FT   MOD_RES         757
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4F3"
FT   MOD_RES         1088
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4F3"
FT   MOD_RES         1090
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4F3"
FT   MOD_RES         1568
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4F3"
FT   CONFLICT        1184
FT                   /note="L -> F (in Ref. 1; BAB82432)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1735 AA;  192642 MW;  9A1999814518EF4C CRC64;
     MEGNGTENPC SRTLGWLHQN NDAKPWLWKF SGCFSLPEQT LPLSSQTKEY MENKKAAVEL
     KDIPSPLHVG SKFFPAVPLP DIHSLQQPKV QLSAIPKVSC CAHCPNEPST SPMPFGGGSG
     SSGRSGSLIH TGSLLDSPST GTVTCQVGSD FAFQSVSSLQ NASARNNLVG LASDLPSMCV
     DSNLPSCKHL SCCGKFHFQS CRSNVHKLHQ FQTLQGCTSA GYFPCSDFPS EAPGHLEEHL
     SHSELTPHLC TNSLHLNVAP PVCLKGSLYC EDCLNKPARN SIIDAAKIWP NIPPPSTQPA
     PRAVPLCNRC GTKGMEKETS LLATSLGKAA SKFGSPEVAV TGQVLETLPP IGVFWDIENC
     SVPSGRSATT VVQRIREKFF RGHREAEFIC VCDISKENKE VIQELNNCQV TVAHINATAK
     NAADDKLRQS LRRFANTHTA PATVVLVSTD VNFALELSDL RHRHGFHIIL VHKNQASEAL
     LHHANQLIRF EEFISDLPPR LPLKIPCHTL LYVYNLPANK DGKSISNRLR RLSDNCGGKV
     LSITGCSAIL RFINQDSAER AQKRMENEDV FGNRIIVSFT PKHRECFEAK SSNAVVDKAK
     SPKKVKNTKL CLIKDTGEQS PSAKAMPGKG LQANSGSATK NTNFKGLQEL CRMEPKSGNR
     IRDHQQGHGS LATLPNSGPT ASVPTLKNTG VRETLHRSSQ KKENLSSQSI ASSPAQKKKR
     EGTVFQISYP SAFSQLIASR QVSPLFSSQS WSPRSMSPNL LNTASPLAFN IANPSSAADC
     SDPFANGVDI QVSNVDYRLS RKELQQLLQE AFSKHGQVKS VELSPHTDYQ LKAIVQMRNL
     HDAICAVNSL HRYKIGSKKI LVSLSTGAAN KSLSLLSTET MSILQDAPAC CLPLFKFIDI
     YEKKYGHKLN VSDLYKLTDM IAIREQGNGR LVCLLPSNQA RQSPLGSSQS HDGSSTNCSP
     VLFEELEYHE SVCKQHCSNK DFSELVFDPD SYKVPFVVLS LKVFAPQVHS LLQTHEGTVP
     LLSFPDCYAA EFGDLEITQD RDKGVPLEHF ITCIPGVNIA TAQNGVKVVK WIHNKPPPPN
     TDPWLLRSKS PVRNPQLIQF SREVIDLLKN QPSCILPISN FIPLYHHHFG KQCRVSDYGY
     SKLIELLEAV PHVLQILGMG SKRLLTLTHR AQVKRFTQDL LKLLKSQASK QVIVSDFSQA
     YHWCFSKDWD VTEYGVCDLI DIISEIPDTT ICLSQQDDDM VICIRKRERT QDEIERTKQF
     SKDVVDLLRH QPHFRMPFNK FIPSYHHHFG RQCKLAYYGF TKLLELLEAI PEILQVLECG
     EEKILTLTEV ERFKALAAQF VKLLRSQKGN CLMMTDLFTE YAKTFGYTFR LQDYDVSSVS
     ALTQKLCHVV KVADMESGKQ IQLITRKSLR PLTVQLLVVL MSWEGDAYLP VDELKRHYET
     THSTPLNPCE YGFMTLTELL KSLPSLVEVF MNDKAEECVK LTSLYLFAKN VRSLLHTYHY
     QQIFLHEFAM AYTKYVGETL QPKTYGYSSV EELLGAIPQV VWIKGHGHKR IVVLKNDMKN
     RLSSFDLSPV NHEDQPAVSR QILEVPEPHL ASELHLRTGP SQMEQELLQL ANSSPVDLLC
     APVPSCLPSP QLRPDPVILQ PTDLIQFEEH PQEPLGVLFL NQEEKTEIPI PVKKGNLSCN
     SSPSSPASAS APPKPSSEAP GLLISKDAVE SPAKKQPKNR VKLAANFSFA PVTKL
//
